Literature DB >> 28652108

Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy.

Barry Moran1, Cheryl M Sweeney2, Rosalind Hughes3, Anna Malara3, Shivashini Kirthi4, Anne-Marie Tobin4, Brian Kirby3, Jean M Fletcher5.   

Abstract

Hidradenitis suppurativa (HS) is a chronic, inflammatory, and debilitating disease of hair follicles with 1-4% prevalence and high morbidity. There is a dearth of information on the pathogenesis and immune dysregulation underlying HS; therefore, we carried out a detailed analysis of skin-infiltrating T cells. Cells isolated from skin biopsy samples and blood from HS patients and healthy control subjects were analyzed by 16-parameter flow cytometry to provide detailed profiles of CD4 T-cell subsets. We observed substantial infiltration of inflammatory T cells with a striking T helper (Th) type 17-skewed cytokine profile in HS skin; these cells expressed the Th17 lineage marker CD161 and IL-17, as well as proinflammatory cytokines GM-CSF, IL-22, IFN-γ, and tumor necrosis factor. Regulatory T cells were also enriched in HS lesional skin; however, the ratio of Th17 to regulatory T cells was nonetheless highly dysregulated in favor of Th17 cells. In contrast, lesional skin from anti-tumor necrosis factor-treated HS patients who showed substantial clinical improvement exhibited a significant reduction in the frequency of Th17 cells and normalization of the Th17 to regulatory T cell ratio. These data suggest that inhibition of pathogenic IL-17 via tumor necrosis factor blockade is associated with improvement in immune dysregulation in HS and may provide a rationale for targeting IL-17 in the disease.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28652108     DOI: 10.1016/j.jid.2017.05.033

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  45 in total

Review 1.  Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.

Authors:  Maran L Sprouse; Nicholas A Bates; Krysta M Felix; Hsin-Jung Joyce Wu
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

Review 2.  The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment.

Authors:  Marisa E Luck; Joy Tao; Eden P Lake
Journal:  Am J Clin Dermatol       Date:  2022-09-18       Impact factor: 6.233

3.  Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.

Authors:  Anna Campanati; Monia Orciani; Giulia Sorgentoni; Veronica Consales; Annamaria Offidani; Roberto Di Primio
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

4.  Collagen deposition in chronic hidradenitis suppurativa: potential role for CD163+ macrophages.

Authors:  A S Byrd; M L Kerns; D W Williams; J C Zarif; A Z Rosenberg; M Delsante; H Liu; C A Dillen; J P Maynard; J A Caffrey; J M Sacks; S M Milner; O Aliu; K P Broderick; L S Lew; L S Miller; S Kang; G A Okoye
Journal:  Br J Dermatol       Date:  2018-06-29       Impact factor: 9.302

5.  The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study.

Authors:  John W Frew; Kristina Navrazhina; David Grand; Mary Sullivan-Whalen; Patricia Gilleaudeau; Sandra Garcet; Jonathan Ungar; James G Krueger
Journal:  J Am Acad Dermatol       Date:  2020-05-13       Impact factor: 11.527

Review 6.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

Review 7.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

8.  Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages.

Authors:  Carmelo Carmona-Rivera; Liam J O'Neil; Eduardo Patino-Martinez; William D Shipman; Chengsong Zhu; Quan-Zhen Li; Michelle L Kerns; Leandra A Barnes; Julie A Caffrey; Sewon Kang; Mariana J Kaplan; Ginette A Okoye; Angel S Byrd
Journal:  J Invest Dermatol       Date:  2021-10-01       Impact factor: 8.551

9.  Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies.

Authors:  J W Frew; K Navrazhina; A S Byrd; A Garg; J R Ingram; J S Kirby; M A Lowes; H Naik; V Piguet; E P Prens
Journal:  Br J Dermatol       Date:  2019-08-29       Impact factor: 11.113

10.  The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.

Authors:  Kristina Navrazhina; Sandra Garcet; John W Frew; Xiuzhong Zheng; Israel Coats; Emma Guttman-Yassky; James G Krueger
Journal:  J Am Acad Dermatol       Date:  2021-07-30       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.